144 related articles for article (PubMed ID: 4429430)
1. Contractile properties of soleus muscle during development in normal and dystrophic mice.
Taylor RG; Fowler WM; Mason DT
Arch Phys Med Rehabil; 1974 Dec; 55(12):531-9. PubMed ID: 4429430
[No Abstract] [Full Text] [Related]
2. Muscle development in mdx mutant mice.
Dangain J; Vrbova G
Muscle Nerve; 1984; 7(9):700-4. PubMed ID: 6543918
[TBL] [Abstract][Full Text] [Related]
3. Energetics of isometric contraction in dystrophic fast and slow muscles.
Nwoye LO; Goldspink G
Muscle Nerve; 1982 Jan; 5(1):69-72. PubMed ID: 7057809
[TBL] [Abstract][Full Text] [Related]
4. Histomorphometrical aspects of the postnatal development of masticatory muscle in the muscular dystrophic mouse.
Vilmann H; Kirkeby S
Anat Anz; 1991; 172(2):109-16. PubMed ID: 2048740
[TBL] [Abstract][Full Text] [Related]
5. Effect of low Ca2+ solution on muscle contraction of developing, preclinical dystrophic (dy2j) mice.
Dangain J; Neering IR
Muscle Nerve; 1992 Jan; 15(1):77-86. PubMed ID: 1732766
[TBL] [Abstract][Full Text] [Related]
6. Exercise effect on contractile properties of skeletal muscle in mouse muscular dystrophy.
Taylor RG; Fowler WM; Doerr L
Arch Phys Med Rehabil; 1976 Apr; 57(4):174-80. PubMed ID: 1267593
[TBL] [Abstract][Full Text] [Related]
7. Different time courses of reduction in muscular potentials to moderate frequency stimulation in dystrophic and normal mice.
Watanabe K; Uramoto I; Totsuka T
Nihon Seirigaku Zasshi; 1982; 44(3):99-102. PubMed ID: 7097610
[TBL] [Abstract][Full Text] [Related]
8. Comparison of force and stiffness in normal and dystrophic mouse muscles.
Gordon T; Stein RB
Muscle Nerve; 1988 Aug; 11(8):819-27. PubMed ID: 3173407
[TBL] [Abstract][Full Text] [Related]
9. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
10. Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse.
Souccar C; Gonçalo Mdo C; Buck Hde S; Lima-Landman MT; Lapa AJ
Neuromuscul Disord; 2005 Jan; 15(1):48-56. PubMed ID: 15639121
[TBL] [Abstract][Full Text] [Related]
11. EDL and soleus muscles of the C57BL6J/dy2j laminin-alpha 2-deficient dystrophic mouse are not vulnerable to eccentric contractions.
Head SI; Bakker AJ; Liangas G
Exp Physiol; 2004 Sep; 89(5):531-9. PubMed ID: 15184359
[TBL] [Abstract][Full Text] [Related]
12. A noninvasive procedure to detect muscle weakness in the mdx mouse.
Carlson CG; Makiejus RV
Muscle Nerve; 1990 Jun; 13(6):480-4. PubMed ID: 2366821
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns in muscular potentials at MG and SOL muscles of dystrophic and normal mice due to prolonged stimulation.
Uramoto I; Watanabe K; Totsuka T
Nihon Seirigaku Zasshi; 1984; 46(3):99-102. PubMed ID: 6747908
[No Abstract] [Full Text] [Related]
14. A study of functional denervation in fast and slow muscles of dystrophic mice of various ages.
Parry DJ
Exp Neurol; 1977 Jun; 55(3 PT. 1):556-66. PubMed ID: 858337
[No Abstract] [Full Text] [Related]
15. Functional improvement of skeletal muscles of dystrophic mice following electrical stimulation [proceedings].
Luthert P; Vrbová G; Ward KM
J Physiol; 1979 Jun; 291():31P. PubMed ID: 314512
[No Abstract] [Full Text] [Related]
16. Beneficial effects of training on developing dystrophic muscle.
Elder GC
Muscle Nerve; 1992 Jun; 15(6):672-7. PubMed ID: 1508231
[TBL] [Abstract][Full Text] [Related]
17. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
McIntosh LM; Pernitsky AN; Anderson JE
Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
[TBL] [Abstract][Full Text] [Related]
18. Mechanical properties of dystrophic mouse muscle.
Harris JB; Wilson P
J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):512-20. PubMed ID: 5122378
[TBL] [Abstract][Full Text] [Related]
19. Membrane alterations in skeletal muscle fibers of dystrophic mice.
Kerr LM; Sperelakis N
Muscle Nerve; 1983 Jan; 6(1):3-13. PubMed ID: 6302500
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
